This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Oct:129:131-63.

doi: 10.1111/j.1600-065x.1992.tb01422.x.

Interleukin-2 receptor-directed immunosuppressive therapies: antibody- or cytokine-based targeting molecules

T B Strom¹, V R Kelley, T G Woodworth, J R Murphy

Affiliations

PMID: 1464418
DOI: 10.1111/j.1600-065x.1992.tb01422.x

Review

Interleukin-2 receptor-directed immunosuppressive therapies: antibody- or cytokine-based targeting molecules

T B Strom et al. Immunol Rev. 1992 Oct.

. 1992 Oct:129:131-63.

doi: 10.1111/j.1600-065x.1992.tb01422.x.

Authors

T B Strom¹, V R Kelley, T G Woodworth, J R Murphy

Affiliation

¹ Department of Medicine, Beth Israel Hospital, Boston, MA.

PMID: 1464418
DOI: 10.1111/j.1600-065x.1992.tb01422.x

No abstract available

PubMed Disclaimer

Similar articles

Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules.
Strom TB, Kelley VR, Murphy JR, Nichols J, Woodworth TG. Strom TB, et al. Adv Nephrol Necker Hosp. 1994;23:347-56. Adv Nephrol Necker Hosp. 1994. PMID: 8154364 Review. No abstract available.
Clinical experience with a monoclonal interleukin-2 receptor antibody (BT 563) for rejection therapy after orthotopic heart transplantation.
Iberer F, Tscheliessnigg KH, Freigassner M, Auer T, Kleinert R, Wasler A, Petutschnigg B, Müller H. Iberer F, et al. Transplant Proc. 1994 Dec;26(6):3237-9. Transplant Proc. 1994. PMID: 7998128 Clinical Trial. No abstract available.
The interleukin-2 receptor: a target for immunotherapy.
Waldmann TA, Goldman C, Top L, Grant A, Burton J, Bamford R, Roessler E, Horak I, Zaknoen S, Kasten-Sportes C, et al. Waldmann TA, et al. Adv Exp Med Biol. 1992;323:57-66. doi: 10.1007/978-1-4615-3396-2_8. Adv Exp Med Biol. 1992. PMID: 1485565 Review. No abstract available.
Effect of anti-IL-2-receptor monoclonal antibody BT 563 in treatment of acute interstitial renal rejection.
Carl S, Wiesel M, Daniel V, Staehler G. Carl S, et al. Transplant Proc. 1995 Feb;27(1):854-5. Transplant Proc. 1995. PMID: 7879205 Clinical Trial. No abstract available.
The interleukin-2 inhibitors and their role in low-toxicity regimens.
Nashan B. Nashan B. Transplant Proc. 1999 Dec;31(8A):23S-26S. doi: 10.1016/s0041-1345(99)00844-1. Transplant Proc. 1999. PMID: 10616557 No abstract available.

See all similar articles

Cited by

Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.
Wilson BA, Ho M. Wilson BA, et al. Curr Top Med Chem. 2014;14(18):2081-93. doi: 10.2174/1568026614666141022094517. Curr Top Med Chem. 2014. PMID: 25335885 Free PMC article. Review.
Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates.
Poirier N, Haudebourg T, Brignone C, Dilek N, Hervouet J, Minault D, Coulon F, de Silly RV, Triebel F, Blancho G, Vanhove B. Poirier N, et al. Clin Exp Immunol. 2011 May;164(2):265-74. doi: 10.1111/j.1365-2249.2011.04329.x. Epub 2011 Feb 24. Clin Exp Immunol. 2011. PMID: 21352204 Free PMC article.
Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the alpha subunit of the receptor.
Richardson JH, Sodroski JG, Waldmann TA, Marasco WA. Richardson JH, et al. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3137-41. doi: 10.1073/pnas.92.8.3137. Proc Natl Acad Sci U S A. 1995. PMID: 7724529 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Wiley